EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autogenic-regenerated intestinal transplantation improves outcomes in short bowel syndrome

Kentaro Iwaki, Takamichi Ishii, Hidenobu Kojima, Fumiaki Munekage, Hiroshi Horie, Kenta Makino, Takuma Karasuyama, Yusuke Hanabata, Elena Yukie Uebayashi, Satoshi Ogiso, Etsuro Hatano

JCI Insight · 22.07.2026 · 11 (14)

DOI: 10.1172/jci.insight.200275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 02.06.2026. Verfasst von Kentaro Iwaki und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Short Bowel Syndrome, Intestine, Small, Regeneration. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small bowel transplantation (SBT) is the only curative treatment for intestinal failure due to short bowel syndrome (SBS); however, the 10-year graft survival rate after SBT remains below 50%. Therefore, alternative treatments are required. We developed a potentially new therapeutic strategy for intestinal failure involving in vivo intestinal regeneration using a decellularized scaffold in a rat model. A 3 cm segment of decellularized small intestine was anastomosed to the jejunum for in vivo regeneration. After 4 weeks of regeneration, the entire native intestine was resected to induce SBS, and the regenerated intestine was transplanted into the same rat. Histological analysis revealed regeneration of mucosa, nerves, muscular layer, and crypts, consistent with autologous cell infiltration. An indocyanine green test confirmed blood flow from the adjacent mesentery into the regenerated intestine. The regenerated intestine exhibited absorption of nutrients in vivo, and ex vivo assessments confirmed peristalsis and absorptive capacity comparable with native intestine. Transplantation of the regenerated intestine significantly improved postoperative nutritional status in SBS rats. Our method, autogenic-regenerated intestinal transplantation, showed the therapeutic potential for intestinal failure. This is the first study to our knowledge to demonstrate a functionally integrated regenerated intestine, providing a foundation for future regenerative therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Short Bowel SyndromeIntestine, SmallRegenerationAnimalsRatsDisease Models, AnimalMaleTransplantation, AutologousIntestinal MucosaGraft SurvivalJejunum

Stichwörter der Autor:innen

DevelopmentGastroenterologyOrgan transplantationTransplantation

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Iwaki, K., Ishii, T., Kojima, H., Munekage, F., Horie, H., Makino, K., Karasuyama, T., Hanabata, Y., Uebayashi, E. Y., Ogiso, S., & Hatano, E. (2026). Autogenic-regenerated intestinal transplantation improves outcomes in short bowel syndrome. JCI Insight, 11(14). https://doi.org/10.1172/jci.insight.200275

Vancouver

Iwaki K, Ishii T, Kojima H, Munekage F, Horie H, Makino K, et al. Autogenic-regenerated intestinal transplantation improves outcomes in short bowel syndrome. JCI Insight. 2026;11(14). doi:10.1172/jci.insight.200275

BibTeX
@article{Iwaki2026,
  author = {Iwaki, Kentaro and Ishii, Takamichi and Kojima, Hidenobu and Munekage, Fumiaki and Horie, Hiroshi and Makino, Kenta and Karasuyama, Takuma and Hanabata, Yusuke and Uebayashi, Elena Yukie and Ogiso, Satoshi and Hatano, Etsuro},
  title = {Autogenic-regenerated intestinal transplantation improves outcomes in short bowel syndrome},
  journal = {JCI Insight},
  year = {2026},
  volume = {11},
  number = {14},
  doi = {10.1172/jci.insight.200275}
}
Kostenlos starten →